EDX — Edx Medical Balance Sheet
0.000.00%
- £36.04m
- £33.20m
- £0.33m
Annual balance sheet for Edx Medical, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | R2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | — | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.03 | 0.116 | 4.07 | 2.4 | 2.92 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.003 | 0.331 | 0.596 | 0.472 | 0.431 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.04 | 0.769 | 4.89 | 2.92 | 3.45 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.001 | 0.845 | 0.589 | 0.386 | 0.367 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1.04 | 1.71 | 5.59 | 3.54 | 3.96 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.053 | 2.37 | 1.95 | 0.94 | 1.78 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.053 | 2.66 | 2.11 | 0.964 | 1.79 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 0.983 | -0.953 | 3.48 | 2.57 | 2.17 |
| Total Liabilities & Shareholders' Equity | 1.04 | 1.71 | 5.59 | 3.54 | 3.96 |
| Total Common Shares Outstanding |